For the latest COVID-19 (Coronavirus) information: CCTG public updates | CCTG member information

Group newsletter: CCTG Connection

Archived Bulletins

November 18, 2020

Published: November 18, 2020
Category: Trials

Great news to share from the CCTG IC8 trial team! The study already has 6 sites currently participating with 29 patients accrued. Congrats to all of the trial teams at:

Read More

November 04, 2020

Published: November 04, 2020
Category: Trials
Trial Closure: BR28
CCTG trials BR28 and BL12 have been permanently closed. Read More

Published: November 04, 2020
Category: Group updates

The CCTG Pharmacy Network is actively seeking pharmacy representation for the Genitourinary Disease Site Committee and the Steering Group - Quebec.

Read More

Lead author Dr. Arjun Sahgal, deputy chief of radiation oncology at the Sunnybrook Health Sciences Centre of the University of Toronto, presented the findings from the CCTG SC24 at the American Society for Radiation Oncology (ASTRO) Annual Meeting last week. This randomized phase II/III trial is the first to show that stereotactic body radiation therapy is superior to conventional radiation treatments in alleviating pain from spinal metastases.
Read More

Published: November 04, 2020
Category: News

The Canadian Cancer Society (CCS) is seeking your input on the development of a new CCS Research Strategy.  
 
As a cancer researcher, CCS is interested in your thoughts about the values, challenges, strengths, and opportunities related to cancer research. This input will inform CCS's cancer research strategy development so that we can be as relevant, supportive and effective as possible with our research funding. 
 

Read More

The Canadian Cancer Society Awards for Excellence in Cancer Research recognize individuals who have made, and are making, valuable contributions to the cancer research ecosystem in Canada. Recipients are leaders in their fields who exemplify excellence in science and outstanding service to the scientific community. There are two new awards this year find out more here.

Read More

Published: November 04, 2020
Category: Publications
Publication: CO17
Publication for CCTG CO17
Loree JM, Dowers A, Tu D, Jonker D, Edelstein DL, Quinn H, Holtrup F, Price T, Zalcberg JR, Moore MJ, Karapetis CS, Callaghan CJ, Waring P, Kennecke HF, Hamilton SR, Kopetz S. Expanded low allele frequency RAS and BRAF V600E testing in metastatic colorectal cancer as predictive biomarkers for cetuximab in the randomized CO.17 trial (ONLINE). Clin Cancer Res clincanres, 2020.
Read More

October 21, 2020

Dr. Cheung and Dr. Hay receive bridge funding - CIHR Spring 2020 competition

Congratulations to Dr. Annette Hay, a Senior Investigator with the Canadian Cancer Trials Group and Dr. Matthew Cheung, Hematologist at Sunnybrook Health Sciences Centre. Together they received $100,000 in bridge funding in the Canadian Institutes of Health Research (CIHR) Spring 2020 competition.

Read More